|Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference|
H Northrup, DA Krueger, S Roberds, K Smith, J Sampson, B Korf, ...
Pediatric neurology 49 (4), 243-254, 2013
|Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference|
DA Krueger, H Northrup, S Roberds, K Smith, J Sampson, B Korf, ...
Pediatric neurology 49 (4), 255-265, 2013
|European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis|
SR Johnson, JF Cordier, R Lazor, V Cottin, U Costabel, S Harari, ...
European Respiratory Journal 35 (1), 14-26, 2010
|Clinical experience of lymphangioleiomyomatosis in the UK|
SR Johnson, AE Tattersfield
Thorax 55 (12), 1052-1057, 2000
|Lymphangioleiomyomatosis: clinical features, management and basic mechanisms|
Thorax 54 (3), 254-264, 1999
European Respiratory Journal 27 (5), 1056-1065, 2006
|Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial|
DM Davies, PJ de Vries, SR Johnson, DL McCartney, JA Cox, AL Serra, ...
Clinical cancer research 17 (12), 4071-4081, 2011
|Synthetic functions of airway smooth muscle in asthma|
SR Johnson, AJ Knox
Trends in pharmacological sciences 18 (4), 288-292, 1997
|Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis|
DM Davies, SR Johnson, AE Tattersfield, JC Kingswood, JA Cox, ...
New England Journal of Medicine 358 (2), 200-203, 2008
|Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment|
SR Johnson, AE Tattersfield
American Journal of Respiratory and Critical Care Medicine 160 (2), 628-633, 1999
|Survival and disease progression in UK patients with lymphangioleiomyomatosis|
SR Johnson, CI Whale, RB Hubbard, SA Lewis, AE Tattersfield
Thorax 59 (9), 800-803, 2004
|Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells|
AM Freyer, SR Johnson, IP Hall
American journal of respiratory cell and molecular biology 25 (5), 569-576, 2001
|Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation|
S Johnson, A Knox
American Journal of Physiology-Lung Cellular and Molecular Physiology 277 (6 …, 1999
|Emerging clinical picture of lymphangioleiomyomatosis|
MM Cohen, S Pollock-BarZiv, SR Johnson
Thorax 60 (10), 875-879, 2005
|Association of MMP-12 polymorphisms with severe and very severe COPD: A case control study of MMP s-1, 9 and 12 in a European population|
I Haq, S Chappell, SR Johnson, J Lotya, L Daly, K Morgan, ...
BMC medical genetics 11 (1), 7, 2010
|Official American Thoracic Society/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management|
FX McCormack, N Gupta, GR Finlay, LR Young, AM Taveira-DaSilva, ...
American journal of respiratory and critical care medicine 194 (6), 748-761, 2016
|Matrix metalloproteinase expression and activity in human airway smooth muscle cells|
SR Elshaw, N Henderson, AJ Knox, SA Watson, DJ Buttle, SR Johnson
British journal of pharmacology 142 (8), 1318-1324, 2004
|Antiproliferative effects of NO and ANP in cultured human airway smooth muscle|
AM Hamad, SR Johnson, AJ Knox
American Journal of Physiology-Lung Cellular and Molecular Physiology 277 (5 …, 1999
|Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis|
EC Harknett, WYC Chang, S Byrnes, J Johnson, R Lazor, MM Cohen, ...
QJM: An International Journal of Medicine 104 (11), 971-979, 2011
|Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case–control study|
V Navaratnam, AW Fogarty, T McKeever, N Thompson, G Jenkins, ...
Thorax 69 (3), 207-215, 2014